8. Which of the following best describes the response rate for monotherapy with programmed cell death protein 1 /programmed
death-ligand 1 inhibitors?
(A) It varies by tumor type, but is never more than 10%
(B) It varies by tumor type, but is usually around 10% to 25%
(C) It varies by tumor type, but is usually around 40% to 50%
(D) It is typically around 50% to 60%